JPRN-UMIN000019446
Recruiting
Phase 2
A study of biomarkers that predict efficacy of or resistance to trastuzumab emtansine for patients with HER2-positive non-small cell lung cancer - Biomarker study of T-DM1 for HER2-positive non-small cell lung cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- HER2-positive, recurrent, non-small cell lung cancer
- Sponsor
- Okayama University
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •There are no special instruction regarding this section.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Exploration of biomarkers to predict the efficacy of immune checkpoint inhibitors in gastric cancer using cell-free RNA.gastric cancerJPRN-UMIN000047448Kyushu University Hospital, Department of Surgery and Science42
Completed
Not Applicable
Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumorsPatients with bone metastases newly treated by zoledronic acidJPRN-UMIN000018556agoya University Graduate School and School of Medicine27
Completed
Not Applicable
Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumorsPatients with bone metastases newly treated by denosumabJPRN-UMIN000019700agoya University Graduate School and School of Medicine40
Completed
Not Applicable
Exploratory study for biomarkers to predict efficacy and toxicity to Sorafenib in patients with advanced hepatocellular carcinomaHepatocellulara carcinomaJPRN-UMIN000008808ational Cancer Center Hospital100
Recruiting
Not Applicable
Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cellsSevere asthmaJPRN-UMIN000050670Department of Respiratory Medicine, University of Tsukuba50